The UCL Technology Fund is in line for an exit from gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.

Dell Technologies Capital will exit Redlock in an acquisition by Palo Alto Networks, five months after it bought another cloud security software developer.

Anju Software has paid an undisclosed sum to acquire healthcare data provider Zephyr Health, which had raised $33.5m from investors including GV.

Industrial robot producer Rethink Robotics had raised $136m from backers including GE Ventures but has ceased trading after failing to close a planned acquisition deal.

Alphabet subsidiary Google has bought RGA-backed customer service chatbot developer Onward to integrate the latter's AI tools with its own technology.

Holiday accommodation booking service Oasis Collections has been picked up by Vacasa after raising $35m in funding from investors including Hyatt and AccorHotels.

The SoftBank-backed precision oncology test developer floated above its range and saw its share price rise 69% on the first day of trading.

Cellular therapy developer Gamida Cell, which counts Novartis as its largest investor, has filed for a $69m initial public offering.

Merck & Co and Takeda are in line for exits when drug developer NGM Biopharmaceuticals lists on the Nasdaq Global Select Market.

The SIG China-backed mobile app developer raised $52.2m despite floating at the bottom of the IPO's range.